Ibugrip Plus (Pseudoephedrine Hydrochloride, Ibuprofen)

Pseudoephedrine hydrochloride acts as an α‑adrenergic agonist, causing constriction of blood vessels in the nasal mucosa. This vasoconstriction reduces swelling and fluid buildup, helping to open nasal passages and improve breathing during congestion.

The appropriate dose of Ibugrip Plus is determined by a qualified prescriber based on the individual’s age, weight, medical condition, and other medications they may be taking. Patients should follow the specific instructions provided by their healthcare professional.

Safety of Ibugrip Plus in pregnancy or while breastfeeding should be evaluated by a healthcare provider. Both ibuprofen and pseudoephedrine have specific considerations, and a doctor will weigh potential benefits against possible risks before recommending use.

To order Ibugrip Plus, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibugrip Plus offers the combined benefits of ibuprofen’s analgesic, antipyretic and anti‑inflammatory effects together with pseudoephedrine’s nasal decongestant action. Using the two agents in a single tablet can simplify dosing for patients who need both pain relief and congestion relief, whereas separate products would require managing two separate medications.

Store Ibugrip Plus at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, excessive heat and direct sunlight to maintain potency and stability.

Ibugrip Plus is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless specifically directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, gastrointestinal bleeding or ulceration, significant elevation of blood pressure, and cardiac arrhythmias. Patients experiencing any of these symptoms should seek immediate medical attention.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or pseudoephedrine should avoid Ibugrip Plus. It is also contraindicated in patients with uncontrolled hypertension, certain heart conditions, severe renal impairment, or those taking monoamine oxidase inhibitors.